Tocilizumab vs. baricitinib in hospitalized severe COVID-19 patients: results from a real-world cohort.
Karolyi M, Gruebl A, Omid S, Saak M, Pawelka E, Hoepler W, Kelani H, Kuran A, Laferl H, Ott C, Pereyra D, Santol J, Seitz T, Traugott M, Assinger A, Wenisch C, Zoufaly A.
Karolyi M, et al. Among authors: ott c.
Infection. 2023 Aug;51(4):851-858. doi: 10.1007/s15010-022-01915-7. Epub 2022 Sep 9.
Infection. 2023.
PMID: 36083403
Free PMC article.